Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 24, 2012 - Issue 7
237
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Are airborne refractory ceramic fibers similar to asbestos in their carcinogenicity?

, &
Pages 416-424 | Received 19 Mar 2012, Accepted 05 Apr 2012, Published online: 30 May 2012

References

  • Berman DW, Crump KS. 2008a. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol 38 Suppl 1:1–47.
  • Berman DW, Crump KS. 2008b. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol 38 Suppl 1:49–73.
  • Bernstein DM, Hoskins JA. 2006. The health effects of chrysotile: current perspective based upon recent data. Regul Toxicol Pharmacol 45:252–264.
  • Berry C. 1999. Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of fibers. Inhal Tox 11:111–130.
  • Brown RC, Bellmann B, Muhle H, Davis JM, Maxim LD. 2005. Survey of the biological effects of refractory ceramic fibres: overload and its possible consequences. Ann Occup Hyg 49:295–307.
  • Burdorf A, Heederik D. 2011. Applying quality criteria to exposure in asbestos epidemiology increases the estimated risk. Ann Occup Hyg 55:565–568.
  • Burge PS, Calvert IA, Trethowan WN, Harrington JM. 1995. Are the respiratory health effects found in manufacturers of ceramic fibres due to the dust rather than the exposure to fibres? Occup Environ Med 52:105–109.
  • Choi EH. 2007. Asbestos exposure: How risky is it? American Council on Science and Health. New York, NY, 33 pp. Available online at: www.acsh.org/docLib/20071015_Asbestos.pdf.
  • Corn M, Esmen NA. 1979. Workplace exposure zones for classification of employee exposures to physical and chemical agents. Am Ind Hyg Assoc J 40:47–57.
  • Cowie HA, Wild P, Beck J, Auburtin G, Piekarski C, Massin N, Cherrie JW, Hurley JF, Miller BG, Groat S, Soutar CA. 2001. An epidemiological study of the respiratory health of workers in the European refractory ceramic fibre industry. Occup Environ Med 58:800–810.
  • Egilman D, Fehnel C, Bohme SR. 2003. Exposing the “myth” of ABC, “anything but chrysotile”: a critique of the Canadian asbestos mining industry and McGill University chrysotile studies. Am J Ind Med 44:540–557.
  • Gibbs GW, Berry G. 2008. Mesothelioma and asbestos. Regul Toxicol Pharmacol 52:S223–S231.
  • Goodman M, Teta MJ, Hessel PA, Garabrant DH, Craven VA, Scrafford CG, Kelsh MA. 2004. Mesothelioma and lung cancer among motor vehicle mechanics: a meta-analysis. Ann Occup Hyg 48:309–326.
  • Health Effects Institute. 1991. Asbestos in public and commercial buildings: A literature review and synthesis of current knowledge. Health Effects Institute—Asbestos Research, Cambridge, MA, 420 pp. Available online at: http://pubs.healtheffects.org/view.php?id=13.
  • Hesterberg TW, Anderson R, Bernstein DM, Bunn WB, Chase GA, Jankousky AL, Marsh GM, McClellan RO. 2012. Product stewardship and science: safe manufacture and use of fiber glass. Regul Toxicol Pharmacol 62:257–277.
  • Hodgson JT, Darnton A. 2000. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 44:565–601.
  • Kanarek MS. 2011. Mesothelioma from chrysotile asbestos: update. Ann Epidemiol 21:688–697.
  • Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J. 1999. The hazards of chrysotile asbestos: a critical review. Ind Health 37:271–280.
  • LeMasters GK, Lockey JE, Yiin JH, Hilbert TJ, Levin LS, Rice CH. 2003. Mortality of workers occupationally exposed to refractory ceramic fibers. J Occup Environ Med 45:440–450.
  • LeMasters GK, Lockey JE, Levin LS, McKay RT, Rice CH, Horvath EP, Papes DM, Lu JW, Feldman DJ. 1998. An industry-wide pulmonary study of men and women manufacturing refractory ceramic fibers. Am J Epidemiol 148:910–919.
  • Lemen RA. 2004. Chrysotile asbestos as a cause of mesothelioma: application of the Hill causation model. Int J Occup Environ Health 10:233–239.
  • Lenters V, Vermeulen R, Dogger S, Stayner L, Portengen L, Burdorf A, Heederik D. 2011. A meta-analysis of asbestos and lung cancer: is better quality exposure assessment associated with steeper slopes of the exposure-response relationships? Environ Health Perspect 119:1547–1555.
  • Li L, Sun TD, Zhang X, Lai RN, Li XY, Fan XJ, Morinaga K. 2004. Cohort studies on cancer mortality among workers exposed only to chrysotile asbestos: a meta-analysis. Biomed Environ Sci 17:459–468.
  • Lockey JE, LeMasters GK, Levin L, Rice C, Yiin J, Reutman S, Papes D. 2002. A longitudinal study of chest radiographic changes of workers in the refractory ceramic fiber industry. Chest 121:2044–2051.
  • Lockey JE, Levin LS, Lemasters GK, McKay RT, Rice CH, Hansen KR, Papes DM, Simpson S, Medvedovic M. 1998. Longitudinal estimates of pulmonary function in refractory ceramic fiber manufacturing workers. Am J Respir Crit Care Med 157:1226–1233.
  • Lockey J, Lemasters G, Rice C, Hansen K, Levin L, Shipley R, Spitz H, Wiot J. 1996. Refractory ceramic fiber exposure and pleural plaques. Am J Respir Crit Care Med 154:1405–1410.
  • Lockey JE, Roggli VL, Hilbert TJ, Rice CH, Levin LS, Borton EK, Biddinger PW, LeMasters GK. 2012. Biopersistence of refractory ceramic fiber (RCF) in human lung tissue and a 20-year follow-up of radiographic pleural changes in workers. J Occup Environ Med (In Press).
  • Mast RW, McConnell EE, Anderson R, Chevalier J, Kotin P, Bernstein DM, Thevenaz P, Glass LR, Miiller WC, Hesterberg TW. 1995a. Studies on the chronic toxicity (inhalation) of four types of refractory ceramic fiber in male Fischer 344 rats. Inhal Toxicol 7:425–467.
  • Mast RW, McConnell EE, Hesterberg TW, Chevalier J, Kotin P, Thevenaz P, Bernstein DM, Glass LR, Miiller W, Anderson R. 1995b. Multiple-dose chronic inhalation toxicity study of size-separated kaolin refractory ceramic fiber in male Fischer 344 rats. Inhal Toxicol 7:469–502.
  • Maxim LD, Allshouse J, Fairfax RE, Lentz TJ, Venturin D, Walters TE. 2008. Workplace monitoring of occupational exposure to refractory ceramic fiber–a 17-year retrospective. Inhal Toxicol 20:289–309.
  • Maxim LD, Yu CP, Oberdörster G, Utell MJ. 2003. Quantitative risk analysis for RCF: Survey and synthesis. Regul Toxicol Pharmacol 56:42–62.
  • McKay RT, LeMasters GK, Hilbert TJ, Levin LS, Rice CH, Borton EK, Lockey JE. 2011. A long term study of pulmonary function among US refractory ceramic fibre workers. Occup Environ Med 68:89–95.
  • Mirabelli D, Calisti R, Barone-Adesi F, Fornero E, Merletti F, Magnani C. 2008. Excess of mesotheliomas after exposure to chrysotile in Balangero, Italy. Occup Environ Med 65:815–819.
  • Nicholson WJ. 1984. Airborne asbestos health assessment update. EPA-600/8-84/003F. Office of Health and Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC, 215 pp.
  • Peto J, Seidman H, Selikoff IJ. 1982. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer 45:124–135.
  • Pierce JS, McKinley MA, Paustenbach DJ, Finley BL. 2008. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma. Crit Rev Toxicol 38:191–214.
  • Pott F, Roller M. 1996. Carcinogenicity of synthetic fibers in experimental animals: Its significance for workers. J Occup Health Safety Aust NZ 12: 333–339.
  • Price B, Ware A. 2005. Mesothelioma: risk apportionment among asbestos exposure sources. Risk Anal 25:937–943.
  • Rice CH, Levin LS, Borton EK, Lockey JE, Hilbert TJ, Lemasters GK. 2005. Exposures to refractory ceramic fibers in manufacturing and related operations: a 10-year update. J Occup Environ Hyg 2:462–473.
  • Rödelsperger K. 2004. Extrapolation of the carcinogenic potency of fibers from rats to humans. Inhal Toxicol 16:801–807.
  • Roller M, Wardenbach P. 2003. Risikoschätzungen für Keramikfasern. VDI-Berichte Nr. 1776: 89–98.
  • Surveillance, Epidemiology and End Results program (SEER), (2011). SEER*Stat Database: Mortality - All COD, Aggregated With State, Total U.S. (1969–2008) <Katrina/Rita Population Adjustment>, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released October 2011. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
  • Trethowan WN, Burge PS, Rossiter CE, Harrington JM, Calvert IA. 1995. Study of the respiratory health of employees in seven European plants that manufacture ceramic fibres. Occup Environ Med 52:97–104.
  • Utell MJ, Maxim LD. 2010. Refractory ceramic fiber (RCF) toxicity and epidemiology: a review. Inhal Toxicol 22:500–521.
  • Walker AM, Maxim LD, Utell M. 2002. Risk analysis for mortality from respiratory tumors in a cohort of refractory ceramic fiber workers. Regul Toxicol Pharmacol 35:95–104.
  • Walkin K, Lloyd G. 2006. A comparison of the risks from different materials containing asbestos. Health and Safety Commission Rpt. No. HSC/06/55, 8 pp. Available online at: www.hse.gov.uk/aboutus/meetings/hscarchive/2006/040706/c55.pdf.
  • World Health Organization. 2011. International statistical classification of diseases and related health problems. - 10th revision, edition 2010. Online database available at: http://www.who.int/classifications/icd/en/index.html.
  • Yarborough CM. 2006. Chrysotile as a cause of mesothelioma: an assessment based on epidemiology. Crit Rev Toxicol 36:165–187.
  • Yarborough CM. 2007. The risk of mesothelioma from exposure to chrysotile asbestos. Curr Opin Pulm Med 13:334–338.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.